Security Snapshot

HAEMONETICS CORP MASS - NOTE 2.500% 6/0 Institutional Ownership

CUSIP: 405024AD2

13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

56

Principal

$660,618,569

Price (% of par)

95.29%

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Principal change
+$11,812,189
Market value change
+$7,702,018
Number of holders
56
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • 405024AD2 - HAEMONETICS CORP MASS - NOTE 2.500% 6/0 is tracked under CUSIP 405024AD2.
  • 56 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 56 to 0 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $628,515,443 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 56 institutions filings for Q1 2026.

Open SEC evidence

Security key

405024AD2

Latest holder period

Q1 2026

13F holders

56

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 56 institutional investors reported holding $660,618,569 in principal (par value) of HAEMONETICS CORP MASS - NOTE 2.500% 6/0.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5
Period Principal Value Change Price (% of par) (Median) Investors
2026 Q2 $0 $0 -$25,718 0
2026 Q1 $660,618,569 $628,515,443 +$7,702,018 95.29% 56
2025 Q4 $648,676,380 $673,971,055 -$183,906,760 103.94% 52
2025 Q3 $635,170,914 $587,520,410 -$13,170,223 92.33% 46
2025 Q2 $693,388,500 $690,801,248 +$690,745,658 99.57% 49
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .